Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX)

CUSIP: 74366E102

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, $0.00001 par value
Shares outstanding
62,457,444
Total 13F shares
44,189,630
Share change
+891,610
Total reported value
$1,144,564,352
Put/Call ratio
159%
Price per share
$25.90
Number of holders
124
Value change
+$27,791,318
Number of buys
63
Number of sells
63

Quarterly Holders Quick Answers

What is CUSIP 74366E102?
CUSIP 74366E102 identifies PTGX - Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX) as of Q1 2021

As of 31 Mar 2021, Protagonist Therapeutics, Inc - Common Stock, $0.00001 par value (PTGX) was held by 124 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 44,189,630 shares. The largest 10 holders included FMR LLC, BVF INC/IL, RTW INVESTMENTS, LP, BlackRock Inc., Consonance Capital Management LP, Johnson & Johnson Innovation - JJDC, Inc., Farallon Capital Management, L.L.C., VANGUARD GROUP INC, STATE STREET CORP, and BAKER BROS. ADVISORS LP. This page lists 124 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.